Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma
- 11 August 2014
- journal article
- other
- Published by Wiley in Histopathology
- Vol. 66 (6), 901-904
- https://doi.org/10.1111/his.12509
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Validation of the VE1 immunostain for the BRAFV600E mutation in melanomaJournal of Cutaneous Pathology, 2014
- Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomasHuman Pathology, 2013
- Immunohistochemical Detection of Mutated BRAF V600E Supports the Clonal Origin of BRAF-Induced Thyroid Cancers Along the Spectrum of Disease ProgressionJournal of Clinical Endocrinology & Metabolism, 2013
- Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive featuresHistopathology, 2013
- Renal Metanephric Adenoma Mimicking Papillary Renal Cell Carcinoma on Computed Tomography: A Case ReportUrologia Internationalis, 2012
- BRAF Mutations in Metanephric Adenoma of the KidneyEuropean Urology, 2012
- Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenomaLaboratory Investigation, 2006
- Clinicopathological Study of Fifty PatientsThe American Journal of Surgical Pathology, 1995